Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: A case report

Transfusion and Apheresis Science

Volumn 31, Issue 1, 2004, Pages 17-20

  Guvenc, Birol ^a   Unsal, Cagatay ^a   Gurkan, Emel ^a   Canataroglu, Abdullah ^a   Saritas, Bunyamin ^a   Evran, Mehtap ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Plasmapheresis; Systemic lupus erythematosus; Thrombotic thrombocytopenic purpura

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; MALE; PLASMAPHERESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 3843054630     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2004.01.012     Document Type: Article

References (26)

1. Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. Arch. Intern. Med. 36:1925;89-93
2. Kennedy S.S., Zacharscki L.R., Beck J.R. Thrombotic thrombocytopenic purpura: analysis of 48 unselected cases. Semin. Thromb. Hemost. 6(4):1980;341-349
3. Petitt R.M. Thrombotic thrombocytopenic purpura: a thirty-year review. Semin. Thromb. Hemost. 6(4):1980;350-355
4. Torok T.J., Holman R.C., Chorba T.L. Increasing mortality from thrombotic thrombocytopenic purpura in the United States - analysis of national mortality data, 1968-1991. Am. J. Hematol. 50(2):1995;84-90
5. Rock G.A., Shumak K.H., Buskard N.A., et al. Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Br. J. Hematol. 103:1998;1031-1036
6. Ridolfi R.L., Bell W.R. Thrombotic thrombocytopenic purpura. Reports of 25 cases and review of the literature. Medicine. 60:1981;413-428
7. Mills J.A. Systemic lupus erythematosus. New Engl. J. Med. 330(26):1994;1871-1879. June 30
8. Fessler B.J. Thrombotic syndromes and autoimmune diseases. Rheum. Dis. Clin. N. Am. 23:1997;461-479
9. Pistiner M., Wallace D.J., Nessim S., et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin. Arthritis Rheum. 21:1991;55-64
10. Hamasaki K., Mimura T., Kanda H., et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin. Rheumatol. 22:2003;355-358
11. Thompson C.E., Damon L.E., Ries C.A. Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 80:1992;1890-1895
12. Rock G.A., Shumak K.H., et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. New Engl. J. Med. 235(325):1991;383-397
13. Moake J.L. Thrombotic microangiopathies. New Engl. J. Med. 347(8):2002;589-600
14. Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J., et al. Unusually large plasma factor VIII von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. New Engl. J. Med. 307:1982;1432-1435
15. Zaverio M.R. von Willebrand factor. Curr. Opin. Hematol. 10:2003;142-149
16. Fujikawa K., Suzuki H., Mcullen B., Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 98:2001;1662-1666
17. Gerritsen H.E., Robles R., Lämmle B., Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 98:2001;1654-1661
18. Lammle B. The role of ADAMTS13 in the evaluation and management of patients with thrombotic thrombocytopnic purpura. American Society of Hematology Education Program Book, Philedelphia, Pennsylvania, December, 2002. p. 319-25
19. Porta C., Caporali R., Montecucco C. Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologica. 84:1999;260-269
20. Niles J.L. Value of test for antineutrophil cytoplasmic antibodies in the diagnosis and treatment of vasculitis. Curr. Opin. Rheumatol. 5:1993;18-24
21. Montecucco C. Role of ANCA in the pathogenesis of Wegener's granulomatosis: a short review. Monaldi Arch. Chest Dis. 49:1994;323-326
22. Moses J., Lichtman S.M., Brody J., Wisch N., Moake J.L. Hairy cell leukemia in association with thrombotic thrombocytopenic purpura and factor VIII antibodies. Leukemia Lymphoma. 22:1996;351-354
23. Tada T., Kishimoto H. An autopsy case of thrombotic thrombocytopenic purpura (TTP) complicated with systemic lupus erythematosus (SLE) - demonstration of anti-platelet antibody. Rinsho Ketsueki. 21:1980;1773-1780
24. Macchi L., Rispal P., Clofent-Sanchez G., et al. Antiplatelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid syndrome: their relationship with the observed thrombocytopenia. Br. J. Haematol. 98:1997;336-341
25. Greenwalt D.E., Lipsky R.H., Ockenhouse C.F., et al. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood. 80:1992;1105-1115
26. Manucci P., Vanoli M., Forza I., Canciani M.T., Scorza R. von Willebrand factor cleaving protease (ADAMIS-13) in123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Hematologica. 88:2003;914-918